Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

The emerging regulatory and investor focus on AI-related issues makes it imperative that boards be well positioned to oversee AI-related risks and opportunities, and exercise care in implementing ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

The global race to harness the power of artificial intelligence (AI) has begun. President Donald Trump got it right from the ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

Artificial intelligence (AI) is often hailed as the defining technology of the 21st century, shaping everything from economic growth to national security. But as global investment in AI ...

The firm is pleased to distribute the Q3/Q4 2024 edition of All Eyes on AI: Regulatory, Litigation, and Transactional Developments, which closely follows the evolving regulatory landscape for ...

A terrific indication of AI’s promise is the 2024 Nobel Prize in chemistry, winners of which used AI to “crack the code” of ...

This article discusses artificial intelligence and how state, federal and international approaches and regulations are taking effect.

Conclusion While still in the early stages, the AI regulatory landscape and expectations are starting to take shape.

When combined with regulatory monitoring services or data feeds, AI can monitor global regulatory developments, providing compliance teams with real-time insights into necessary adjustments.

The firm is pleased to distribute the Q1 2024 edition of All Eyes on AI: Regulatory, Litigation, and Transactional Developments, which closely follows ...